MKI67 and metabolic dysfunction-associated steatohepatitis: The KEGG analysis showed that the cancer pathway was the second most enriched pathway, suggesting high-dose SC treatment significantly decreased the mRNA levels of cancer markers such as Tnf-α, α-fetoprotein (Afp), and Ki67 in NASH mice (Figure 6F).